Mark S. Talamonti

NorthShore University HealthSystem

Papers

7

Total Citations

110

H-Index

4

About

Dr. Mark S. Talamonti is a leading hepatopancreatobiliary (HPB) surgeon whose research focuses on advancing minimally invasive surgical techniques, particularly robotic pancreatic and liver surgery. His major contributions center on demonstrating the safety and efficacy of robotic pancreaticoduodenectomy (RPD) compared to traditional open approaches. Using large-scale NSQIP database analyses with propensity score matching, his work has shown that RPD significantly reduces the risk of clinically relevant postoperative pancreatic fistula and overall complications, with key papers accumulating over 40 and 36 citations respectively. He has also investigated bile leak incidence following hepatectomy and risk factors for unplanned conversion during minimally invasive liver surgery. Notably, Dr. Talamonti is pioneering surgical education through his work on a residency robotic biotissue curriculum, preparing the next generation of surgeons for robotic practice. His recent multicenter analysis extends these benefits to octogenarians, showing reduced morbidity and mortality with robotic approaches in elderly patients. With over 110 total citations, Dr. Talamonti’s research is shaping evidence-based guidelines for robotic HPB surgery and training.

Research Focus

Key Achievements

4
H-Index
7
Papers
110
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Risk factors for complications in patients undergoing pancreaticoduodenectomy: A NSQIP analysis with propensity score matching
40 citations · 2020
📈 Most Prolific Year: 2025 (3 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: NorthShore University HealthSystem

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago